Clinical Trials Sponsored by Läkare mot AIDS Forskningsfond
Total 1 results
-
Swedish Institute for Infectious Disease ControlThe Swedish Research Council; European Union; Läkare mot AIDS ForskningsfondCompleted
Sponsors and Collaborators
- Diego Hernan Giunta, MD
- Alberta Children's Hospital, Calgary, Canada
- Norsk Proteinintolerance, Norway
- CRMBM-CEMEREM
- Victor Montori
- Rui-hua Xu, MD, PhD
- San MediTech(Huzhou)Co.,Ltd.
- Elim Pediatric Pharmaceuticals Inc.
- Donders Institute for Brain, Cognition and Behavior
- Celtaxsys Aus Pty Limited
- Cardresearch
- AMTC & Associates
- ProteoSys AG
- The Fifth Affiliated Hospital of Zunyi Medical College
- Fondren Orthopedic Group L.L.P.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- University Medical Center Goettingen
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Caritas Freetown
- Societa Italiana di Endoscopia Digestiva
- View Full List
Medical Conditions
- Auditory Hallucination, Verbal
- Fever, Sweats, and Hot Flashes
- Disturbance of Activity and Attention
- Tularaemia
- Lymphedema of Arm
- Non-compressible Torso Hemorrhage
- Plasmodium Falciparum Malaria (Drug Resistant)
- Spermatogenesis Arrest
- Malignant Ascites Due to Epithelial Carcinoma
- Non-dystrophic Myotonias
- Prostate Cancer Recurrent
- Fibromyalgia Syndrome, Primary
- Orbital Tumor
- Tube Disorders Eustachian
- Normal Diameter of Optic Nerve
- Gynecologic Cancer
- Postcomatose Unawareness State
- Atrial Fibrillation, Postoperative
- Stereotactic Radioablation for Ventricular Tachycardia
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- View Full List
Drug Interventions
- Flibanserin 100 mg dose every evening
- Bortezomib/dexamethasone
- Ruxolitinib
- Topotecan
- Epimedium Prenylflavonoids Extract
- Cetrorelix 78 mg + 78 mg
- Lamivudine
- Enzalutamide, Abiraterone
- Methotrexate
- Mupirocin Calcium
- Polyethylene glycol 3350
- Atezolizumab
- Insulin
- Indoximod
- SERETIDE Diskus
- Cytarabine ARA-C
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Oxycodone, fentanyl
- PF-00868554
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Armenia
- Contract Research Organizations in Australia
- Contract Research Organizations in Brazil
- Contract Research Organizations in India
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Norway
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Serbia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Togo
- Contract Research Organizations in United States
- CRO list by country